Favipir 200
Favipiravir is a novel influenza antiviral medication. Favipiravir ribosyl triphosphate (favipiravir RTP) is metabolized by an intracellular enzyme, and favipiravir RTP specifically inhibits influenza virus RNA polymerase (RNA-dependent RNA polymerase), halting influenza virus reproduction. It's a medicine with a different mode of action than existing influenza antiviral treatments, and it's effective against all types and sub-types of human influenza A, B, and C viruses in vitro, as well as avian and swine viruses.
Favipiravir is a novel influenza antiviral medication. Favipiravir ribosyl triphosphate (favipiravir RTP) is metabolized by an intracellular enzyme, and favipiravir RTP specifically inhibits influenza virus RNA polymerase (RNA-dependent RNA polymerase), halting influenza virus reproduction. It's a medicine with a different mode of action than existing influenza antiviral treatments, and it's effective against all types and sub-types of human influenza A, B, and C viruses in vitro, as well as avian and swine viruses.
Favipiravir is a novel influenza antiviral medication. Favipiravir ribosyl triphosphate (favipiravir RTP) is metabolized by an intracellular enzyme, and favipiravir RTP specifically inhibits influenza virus RNA polymerase (RNA-dependent RNA polymerase), halting influenza virus reproduction. It's a medicine with a different mode of action than existing influenza antiviral treatments, and it's effective against all types and sub-types of human influenza A, B, and C viruses in vitro, as well as avian and swine viruses.
Dosage & Administration
The usual adult dosage is 1600 mg of Favipiravir administered orally twice daily on Day 1, followed by 600 mg orally twice daily from Day 2 to Day 5 or as directed by physicians. The total treatment duration should be 5 days.
Interaction of Favipir 200
Reduced RBC production, as well as elevations in liver function markers such as AST, ALP, ALT, and total bilirubin, as well as enhanced vacuolization in hepatocytes, were observed in animal investigations. There isn't a lot of information about Favipiravir's toxicity in people.
Contraindications
Pregnant women and women who may become pregnant should avoid taking favipiravir.
Side Effects of Favipir 200
Diarrhea and a rise in blood uric acid levels are the most common side effects.
Pregnancy & Lactation
During the early stages of pregnancy, favipiravir may cause embryos to develop slowly or die. It should not be given to a pregnant woman.
Precautions & Warnings
Favipiravir should not be administered to pregnant women, and in women of reproductive potential, confirmation of non-pregnancy is required before usage, as well as strict contraception measures from the commencement of therapy to 7 days after the completion of treatment. Patients with hepatic and renal impairment should exercise caution or use Favipiravir only if directed by a licensed physician.
Therapeutic Class
Anti-viral drugs
Storage Conditions
Keep the temperature below 30°C and keep it away from light and moisture. Keep out of children's reach.